DELRAY BEACH, Fla., Aug. 31, 2026 /PRNewswire/ — According to MarketsandMarkets™, the Oligonucleotide CDMO Market is projected to reach USD 11.14 billion by 2031 from USD 3.88 billion in 2026, at a CAGR of 23.5% during the forecast period. Browse 400 market data Tables and 50 Figures spread through 300 Pages and in-depth TOC on "Oligonucleotide CDMO Market – Global Forecast to 2031" Oligonucleotide CDMO Market Size & Forecast: Market Size Available for Years: 2026–2031 2026 Market Size: USD 3.88 billion 2031 Projected Market Size: USD 11.14 billion CAGR (2026–2031): 23.5% Oligonucleotide CDMO Market Trends & Insights: North America accounted for 43.2% of the oligonucleotide…